Pharmaceutical and Life Sciences Real World Evidence Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)
Pharmaceutical and Life Sciences Real World Evidence Market is Segmented By Type of Applications (Early-Stage Research, Clinical Development, Regulatory Approval, Pricing / Reimbursement, Post Approval Studies), By Type of Real-World Data Sources (Medical Claims, Clinical Trials, Clinical Setting, Patient Powered, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa). The report offers the value (in USD billion) for the above-mentioned segments.
Pharmaceutical and Life Sciences Real World Evidence Market Size
Market Size in USD
CAGR15%
| Study Period | 2024 - 2031 |
| Base Year of Estimation | 2023 |
| CAGR | 15% |
| Market Concentration | Medium |
| Major Players | Clinerion, Clinigen Group, Cognizant Analytics, Evidera, HealthCore |
please let us know !
Pharmaceutical and Life Sciences Real World Evidence Market Analysis
The Pharmaceutical and Life Sciences Real World Evidence Market is estimated to be valued at USD 2.0 billion in 2024 and is expected to reach USD 5.3 billion by 2031, growing at a compound annual growth rate (CAGR) of 15% from 2024 to 2031.
The market is witnessing positive trends owing to rise in usage of real-world data to assess relative effectiveness and safety of treatment options. Pharmaceutical companies are increasingly leveraging real world evidence to expedite clinical development, better target patient populations, and improve health outcomes.